New research links inflammaging and immunosenescence to Alzheimer’s and Parkinson’s, with immune-modulating therapies showing early promise. Aging of the immune system accelerates brain di...
Explore how partial reprogramming using Yamanaka factors reverses epigenetic aging, with recent advances in mice and early clinical trials paving the way for rejuvenation therapies. Partial reprogramm...
A major study reveals aging is a coordinated epigenetic program, not random damage. Single-cell ATAC-seq of 7 million cells shows stereotyped changes across organs, with therapeutic implications. New ...
Recent studies reveal that immune aging, or ‘inflammaging,’ is a modifiable risk factor for neurodegenerative diseases, with new biomarkers and senolytic drugs offering hope for early inte...
A new study in Aging Cell uncovers a bidirectional feedback loop between intestinal aging and gut microbiome changes, accelerating systemic inflammation. A study in Aging Cell reveals how age-related ...
New research links eusociality to extreme longevity, revealing mechanisms like hyaluronic acid and epigenetic reprogramming that could inspire human anti-aging therapies. Eusocial species live excepti...
New research reveals an inverse relationship between cancer and neurodegenerative diseases, offering evolutionary insights for dual therapies targeting healthy aging. Could the same biological pathway...
A groundbreaking study in Science shows OpenAI’s o1-preview model surpasses physicians in diagnostics with limited data, yet struggles with ‘cannot-miss’ cases, suggesting a hybrid f...
New UK Biobank study links PM2.5 and NO2 to accelerated epigenetic aging and brain shrinkage, emphasizing the need for pollution control. Long-term exposure to air pollution may accelerate biological ...
New actigraphy data shows naps over 1 hour are associated with 33% higher mortality and increased Alzheimer’s pathology, but causation remains unclear. Excessive daytime napping may signal under...